EPISODE · Dec 14, 2022 · 9 MIN
Predicting Invasive Lobular Carcinoma Prognosis Through Absence of Lobular Carcinoma in Situ
from Oncology Data Advisor · host i3 Health
In this interview, Dr. Jason Mouabbi speaks with Oncology Data Advisor about his research regarding the absence of lobular carcinoma in situ as a poor prognostic marker in invasive lobular carcinoma, which will be presented as a poster at the 2022 San Antonio Breast Cancer Symposium (SABCS).
What this episode covers
In this interview, Dr. Jason Mouabbi speaks with Oncology Data Advisor about his research regarding the absence of lobular carcinoma in situ as a poor prognostic marker in invasive lobular carcinoma, which will be presented as a poster at the 2022 San Antonio Breast Cancer Symposium (SABCS).
NOW PLAYING
Predicting Invasive Lobular Carcinoma Prognosis Through Absence of Lobular Carcinoma in Situ
No transcript for this episode yet
Similar Episodes
Jun 20, 2026 ·2m
Jun 15, 2026 ·3m
Jun 14, 2026 ·2m
Jun 13, 2026 ·3m
Jun 12, 2026 ·3m
Jun 11, 2026 ·3m